Historique
Bulletin de Périodique
International Journal of Drug Policy , Vol.96 - October 2021 - Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs
Paru le :
01/10/2021
Année
2021
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
- Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs [Editorial]. Grebely J., Collins A.B., Artenie A.A., Sutherland R., Meyer J.P., Barocas J.A., et al., art. 103469.
- Hepatitis C treatment and reinfection surveillance among people who inject drugs in a low-threshold program in Oslo, Norway. Midgard H., Ulstein K., Backe O., Foshaug T., Sorli H., Vennesland K., et al., art. 103165.
- Overdose mortality is reducing the gains in life expectancy of antiretroviral-treated people living with HIV in British Columbia, Canada. St-Jean M., Dong X., Tafessu H., Moore D., Honer W.G., Vila-Rodriguez F., et al., art. 103195.
- "Stigma is where the harm comes from": Exploring expectations and lived experiences of hepatitis C virus post-treatment trajectories among people who inject drugs. Goodyear T., Brown H., Browne A.J., Hoong P., Ti L., Knight R., art. 103238.
- Prevalence and correlates of multiple non-fatal opioid overdoses among people who inject drugs who utilise needle syringe programs in Australia. Geddes L., Iversen J., Darke S., Dietze P., Maher L., art. 103245.
- Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis. Amoako A., Ortiz-Paredes D., Engler K., Lebouché B., Klein M.B., art. 103247.
- "You don't have to squirrel away in a staircase": Patient motivations for attending a novel supervised drug consumption service in acute care. Kosteniuk B., Salvalaggio G., McNeil R., Brooks H.L., Dong K., Twan S., et al., art. 103275.
- The wound that closes doors: Lived experiences and complexities of injection-related injuries and infections among people who inject drugs through an ethnographic lens. Khan S.I., Irfan S.D., Khan M.N.M., Shafiq T.K.I., art. 103276.
- Adherence to antiretroviral therapy among HIV positive men who inject drugs in Pakistan. Iversen J., Qureshi S.u.H., Zafar M., Busz M., Maher L., art. 103281.
- Linking criminal justice-involved individuals to HIV, Hepatitis C, and opioid use disorder prevention and treatment services upon release to the community: Progress, gaps, and future directions. Taweh N., Schlossberg E., Frank C., Nijhawan A., Kuo I., Knight K., et al., art. 103283.
- Towards equity for people who inject drugs in HIV prevention drug trials. Brody J.K., Taylor J., Biello K., Bazzi A.R., art. 103284.
- "You need money to get high, and that's the easiest and fastest way:" A typology of sex work and health behaviours among people who inject drugs. Ogden S.N., Harris M.T.H., Childs E., Valente P.K., Edeza A., Collins A.B., et al., art. 103285.
- Increasing drug-related mortality rates over the last decade in Scotland are not just due to an ageing cohort: A retrospective longitudinal cohort study. McDonald S.A., McAuley A., Hickman M., Bird S.M., Weir A., Templeton K., et al., art. 103286.
- High occurrence of witnessing an opioid overdose in a sample of women who use heroin in Tanzania: Implications for overdose prevention. Saleem H.T., Likindikoki S., Nonyane B.A.S., Mbwambo J., Latkin C., art. 103287.
- Online interventions to reduce stigma towards population groups affected by blood borne viruses in Australia. Broady T.R., Brener L., Vuong T., Cama E., Treloar C., art. 103292.
- A systematic review and meta-analysis of the prevalence of take-home naloxone (THN) ownership and carriage. Burton G., McAuley A., Schofield J., Yeung A., Matheson C., Parkes T., art. 103298.
- Evaluation of the scale-up of HIV testing among people who inject drugs in Scotland in the context of an ongoing HIV outbreak. Trayner K.M.A., Palmateer N.E., McAuley A., Metcalfe R., Goldberg D.J., Peters E., et al., art. 103304.
- Gender-specific associations between psychological distress and injecting risk behaviours among people who inject drugs in Montreal, Canada. Minoyan N., Hoj S.B., Jutras-Aswad D., Vlad D., Martel-Laferrière V., Sylvestre M.-P., et al., art. 103319.
- Conceptualising hepatitis C stigma: A thematic synthesis of qualitative research. Harris M., Guy D., Picchio C.A., White T.M., Rhodes T., Lazarus J.V., art. 103320.
- Community-based assessment and treatment of hepatitis C virus-related liver disease, injecting drug and alcohol use amongst people who are homeless: a systematic review and meta-analysis. Hashim A., Macken L., Jones A.M., McGeer M., Aithal G.P., Verma S., art. 103342.
- Can hepatitis C elimination targets be sustained among people who inject drugs post-2030? Lanièce Delaunay C., Godin A., Kronfli N., Panagiotoglou D., Cox J., Alary M., et al., art. 103343.
- Implementing opt-out hepatitis C virus (HCV) screening in Canadian provincial prisons: A model-based cost-effectiveness analysis. Duchesne L., Dussault C., Godin A., Maheu-Giroux M., Kronfli N., art. 103345.
- Drug use stigma and its association with active hepatitis C virus infection and injection drug use behaviors among community-based people who inject drugs in India. Patel E.U., Solomon S.S., Lucas G.M., McFall A.M., Tomori C., Srikrishnan A.K., et al., art. 103354.
- Utilising an access to care integrated framework to explore the perceptions of hepatitis C treatment of hospital-based interventions among people who use drugs. Levander X.A., Vega T.A., Seaman A., Korthuis P.T., Englander H., art. 103356.
- A hepatitis C elimination model in healthcare for the homeless organization: A novel reflexive laboratory algorithm and equity assessment. Seaman A., King C.A., Kaser T., Geduldig A., Ronan W., Cook R., et al., art. 103359.
- Addressing multiple overdoses: Opportunities for prevention and innovation. Bagley S.M., Hadland S.E., art. 103382.
- Barriers to hepatitis C treatment among secondary needle and syringe program clients and opportunities to intervene. Gunn J., McNally S., Ryan J., Layton C., Bryant M., Walker S., et al., art. 103387.
- Cost-effectiveness of mass screening for hepatitis C virus among all inmates in an Irish prison. Ward Z., Mafirakureva N., Stone J., Keevans M., Betts-Symonds G., Crowley D., et al., art. 103394.
- Machine learning takes a village: Assessing neighbourhood-level vulnerability for an overdose and infectious disease outbreak. Yedinak J.L., Li Y., Krieger M.S., Howe K., Ndoye C.D., Lee H., et al., art. 103395.
- Assessing HIV and overdose risks for people who use drugs exposed to compulsory drug abstinence programs (CDAP): A systematic review and meta-analysis. Vo A.T., Magana C., Hickman M., Borquez A., Beletsky L., Martin N.K., et al., art. 103401.
- Hepatitis C treatment at a Swedish needle exchange program, a successful model of care - the ACTIONNE study. Blomé M.A., Brabäck M., Alsterberg S., Jerkeman A., art. 103407.
- Reinfection following successful direct-acting antiviral therapy for HCV infection among people attending an inner-city community health centre in Victoria, Canada. Selfridge M., Cunningham E.B., Barnett T., Drost A., Gray-Schleihauf C., Guarasci K., et al., art. 103418.
- Diversity of incarceration patterns among people who inject drugs and the association with incident hepatitis C virus infection. Artenie A.A., Hickman M., Vickerman P., Stone J., Grebely J., Bruneau J., art. 103419.
- Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study. Conway A., Valerio H., Peacock A., Degenhardt L., Hayllar J., Harrod M.E., et al., art. 103421.
- Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohort. Carson J.M., Hajarizadeh B., Hanson J., O'Beirne J., Iser D., Read P., et al., art. 103422.
- Detection of active hepatitis C in a single visit and linkage to care among marginalized people using a mobile unit in Madrid, Spain. Ryan P., Valencia J., Cuevas G., Torres-Macho J., Troya J., Pueyo A., et al., art. 103424.
- Hepatitis C reinfection following successful direct-acting antiviral therapy among patients attending a multidisciplinary treatment centre for people who use drugs in Zurich, Switzerland. Falcato L., Bernardini C., Bruggmann P., art. 103434.
- "With a PICC line, you never miss": The role of peripherally inserted central catheters in hospital care for people living with HIV/HCV who use drugs. Guta A., Perri M., Strike C., Gagnon M., Carusone S.C., art. 103438.
- Injecting frequency trajectories and hepatitis C virus acquisition: Findings from a cohort of people who inject drugs in Montréal, Canada. Fortier E., Hoj S.B., Sylvestre M.-P., Artenie A.A., Minoyan N., Jutras-Aswad D., et al., art. 103439.
- Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs [Editorial]. Grebely J., Collins A.B., Artenie A.A., Sutherland R., Meyer J.P., Barocas J.A., et al., art. 103469.
- Hepatitis C treatment and reinfection surveillance among people who inject drugs in a low-threshold program in Oslo, Norway. Midgard H., Ulstein K., Backe O., Foshaug T., Sorli H., Vennesland K., et al., art. 103165.
- Overdose mortality is reducing the gains in life expectancy of antiretroviral-treated people living with HIV in British Columbia, Canada. St-Jean M., Dong X., Tafessu H., Moore D., Honer W.G., Vila-Rodriguez F., et al., art. 103195.
- "Stigma is where the harm comes from": Exploring expectations and lived experiences of hepatitis C virus post-treatment trajectories among people who inject drugs. Goodyear T., Brown H., Browne A.J., Hoong P., Ti L., Knight R., art. 103238.
- Prevalence and correlates of multiple non-fatal opioid overdoses among people who inject drugs who utilise needle syringe programs in Australia. Geddes L., Iversen J., Darke S., Dietze P., Maher L., art. 103245.
- Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis. Amoako A., Ortiz-Paredes D., Engler K., Lebouché B., Klein M.B., art. 103247.
- "You don't have to squirrel away in a staircase": Patient motivations for attending a novel supervised drug consumption service in acute care. Kosteniuk B., Salvalaggio G., McNeil R., Brooks H.L., Dong K., Twan S., et al., art. 103275.
- The wound that closes doors: Lived experiences and complexities of injection-related injuries and infections among people who inject drugs through an ethnographic lens. Khan S.I., Irfan S.D., Khan M.N.M., Shafiq T.K.I., art. 103276.
- Adherence to antiretroviral therapy among HIV positive men who inject drugs in Pakistan. Iversen J., Qureshi S.u.H., Zafar M., Busz M., Maher L., art. 103281.
- Linking criminal justice-involved individuals to HIV, Hepatitis C, and opioid use disorder prevention and treatment services upon release to the community: Progress, gaps, and future directions. Taweh N., Schlossberg E., Frank C., Nijhawan A., Kuo I., Knight K., et al., art. 103283.
- Towards equity for people who inject drugs in HIV prevention drug trials. Brody J.K., Taylor J., Biello K., Bazzi A.R., art. 103284.
- "You need money to get high, and that's the easiest and fastest way:" A typology of sex work and health behaviours among people who inject drugs. Ogden S.N., Harris M.T.H., Childs E., Valente P.K., Edeza A., Collins A.B., et al., art. 103285.
- Increasing drug-related mortality rates over the last decade in Scotland are not just due to an ageing cohort: A retrospective longitudinal cohort study. McDonald S.A., McAuley A., Hickman M., Bird S.M., Weir A., Templeton K., et al., art. 103286.
- High occurrence of witnessing an opioid overdose in a sample of women who use heroin in Tanzania: Implications for overdose prevention. Saleem H.T., Likindikoki S., Nonyane B.A.S., Mbwambo J., Latkin C., art. 103287.
- Online interventions to reduce stigma towards population groups affected by blood borne viruses in Australia. Broady T.R., Brener L., Vuong T., Cama E., Treloar C., art. 103292.
- A systematic review and meta-analysis of the prevalence of take-home naloxone (THN) ownership and carriage. Burton G., McAuley A., Schofield J., Yeung A., Matheson C., Parkes T., art. 103298.
- Evaluation of the scale-up of HIV testing among people who inject drugs in Scotland in the context of an ongoing HIV outbreak. Trayner K.M.A., Palmateer N.E., McAuley A., Metcalfe R., Goldberg D.J., Peters E., et al., art. 103304.
- Gender-specific associations between psychological distress and injecting risk behaviours among people who inject drugs in Montreal, Canada. Minoyan N., Hoj S.B., Jutras-Aswad D., Vlad D., Martel-Laferrière V., Sylvestre M.-P., et al., art. 103319.
- Conceptualising hepatitis C stigma: A thematic synthesis of qualitative research. Harris M., Guy D., Picchio C.A., White T.M., Rhodes T., Lazarus J.V., art. 103320.
- Community-based assessment and treatment of hepatitis C virus-related liver disease, injecting drug and alcohol use amongst people who are homeless: a systematic review and meta-analysis. Hashim A., Macken L., Jones A.M., McGeer M., Aithal G.P., Verma S., art. 103342.
- Can hepatitis C elimination targets be sustained among people who inject drugs post-2030? Lanièce Delaunay C., Godin A., Kronfli N., Panagiotoglou D., Cox J., Alary M., et al., art. 103343.
- Implementing opt-out hepatitis C virus (HCV) screening in Canadian provincial prisons: A model-based cost-effectiveness analysis. Duchesne L., Dussault C., Godin A., Maheu-Giroux M., Kronfli N., art. 103345.
- Drug use stigma and its association with active hepatitis C virus infection and injection drug use behaviors among community-based people who inject drugs in India. Patel E.U., Solomon S.S., Lucas G.M., McFall A.M., Tomori C., Srikrishnan A.K., et al., art. 103354.
- Utilising an access to care integrated framework to explore the perceptions of hepatitis C treatment of hospital-based interventions among people who use drugs. Levander X.A., Vega T.A., Seaman A., Korthuis P.T., Englander H., art. 103356.
- A hepatitis C elimination model in healthcare for the homeless organization: A novel reflexive laboratory algorithm and equity assessment. Seaman A., King C.A., Kaser T., Geduldig A., Ronan W., Cook R., et al., art. 103359.
- Addressing multiple overdoses: Opportunities for prevention and innovation. Bagley S.M., Hadland S.E., art. 103382.
- Barriers to hepatitis C treatment among secondary needle and syringe program clients and opportunities to intervene. Gunn J., McNally S., Ryan J., Layton C., Bryant M., Walker S., et al., art. 103387.
- Cost-effectiveness of mass screening for hepatitis C virus among all inmates in an Irish prison. Ward Z., Mafirakureva N., Stone J., Keevans M., Betts-Symonds G., Crowley D., et al., art. 103394.
- Machine learning takes a village: Assessing neighbourhood-level vulnerability for an overdose and infectious disease outbreak. Yedinak J.L., Li Y., Krieger M.S., Howe K., Ndoye C.D., Lee H., et al., art. 103395.
- Assessing HIV and overdose risks for people who use drugs exposed to compulsory drug abstinence programs (CDAP): A systematic review and meta-analysis. Vo A.T., Magana C., Hickman M., Borquez A., Beletsky L., Martin N.K., et al., art. 103401.
- Hepatitis C treatment at a Swedish needle exchange program, a successful model of care - the ACTIONNE study. Blomé M.A., Brabäck M., Alsterberg S., Jerkeman A., art. 103407.
- Reinfection following successful direct-acting antiviral therapy for HCV infection among people attending an inner-city community health centre in Victoria, Canada. Selfridge M., Cunningham E.B., Barnett T., Drost A., Gray-Schleihauf C., Guarasci K., et al., art. 103418.
- Diversity of incarceration patterns among people who inject drugs and the association with incident hepatitis C virus infection. Artenie A.A., Hickman M., Vickerman P., Stone J., Grebely J., Bruneau J., art. 103419.
- Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study. Conway A., Valerio H., Peacock A., Degenhardt L., Hayllar J., Harrod M.E., et al., art. 103421.
- Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohort. Carson J.M., Hajarizadeh B., Hanson J., O'Beirne J., Iser D., Read P., et al., art. 103422.
- Detection of active hepatitis C in a single visit and linkage to care among marginalized people using a mobile unit in Madrid, Spain. Ryan P., Valencia J., Cuevas G., Torres-Macho J., Troya J., Pueyo A., et al., art. 103424.
- Hepatitis C reinfection following successful direct-acting antiviral therapy among patients attending a multidisciplinary treatment centre for people who use drugs in Zurich, Switzerland. Falcato L., Bernardini C., Bruggmann P., art. 103434.
- "With a PICC line, you never miss": The role of peripherally inserted central catheters in hospital care for people living with HIV/HCV who use drugs. Guta A., Perri M., Strike C., Gagnon M., Carusone S.C., art. 103438.
- Injecting frequency trajectories and hepatitis C virus acquisition: Findings from a cohort of people who inject drugs in Montréal, Canada. Fortier E., Hoj S.B., Sylvestre M.-P., Artenie A.A., Minoyan N., Jutras-Aswad D., et al., art. 103439.
Cote :
Abonnement
Dépouillements
Ajouter le résultat à votre sélection
B. KOSTENIUK ;
G. SALVALAGGIO ;
R. MCNEIL ;
H. L. BROOKS ;
K. DONG ;
S. TWAN ;
J. BROUWER ;
E. HYSHKA
|
2021
Dans International Journal of Drug Policy (Vol.96, October 2021) Article : Périodique
Dans International Journal of Drug Policy (Vol.96, October 2021) Article : Périodique
Background: Acute care hospitals have been described as a high risk environment for people who use drugs (PWUD). Formal and informal bans on drug use can lead patients to conceal their use and consume under unsafe circumstances. Provision of hos[...]
S. I. KHAN ;
S. D. IRFAN ;
M. N. M. KHAN ;
T. K. I. SHAFIQ
|
2021
Dans International Journal of Drug Policy (Vol.96, October 2021) Article : Périodique
Dans International Journal of Drug Policy (Vol.96, October 2021) Article : Périodique
Background: Besides HIV, people who inject drugs (PWID) experience other biomedical adversities, including injection-related injuries and infections. Yet, they are often inadequately addressed due to the prioritisation of HIV-related issues. Thi[...]
S. A. McDONALD ;
A. McAULEY ;
M. HICKMAN ;
S. M. BIRD ;
A. WEIR ;
K. TEMPLETON ;
R. GUNSON ;
S. J. HUTCHINSON
|
2021
Dans International Journal of Drug Policy (Vol.96, October 2021) Article : Périodique
Dans International Journal of Drug Policy (Vol.96, October 2021) Article : Périodique
Background: In Europe, North America, and Australia, mortality due to drug-related (DR) causes amongst people who inject drugs (PWID) is a major issue. Our objective was to characterise temporal trends in DR mortality rates in a large cohort of [...]
C. LANIECE DELAUNAY ;
A. GODIN ;
N. KRONFLI ;
D. PANAGIOTOGLOU ;
J. COX ;
M. ALARY ;
M. B. KLEIN ;
M. MAHEU-GIROUX
|
2021
Dans International Journal of Drug Policy (Vol.96, October 2021) Article : Périodique
Dans International Journal of Drug Policy (Vol.96, October 2021) Article : Périodique
Background: In high-income countries, people who inject drugs (PWID) are a priority population for eliminating hepatitis C virus (HCV) by 2030. Despite evidence informing micro-elimination strategies, little is known regarding efforts needed to [...]
E. FORTIER ;
S. B. HOJ ;
M. P. SYLVESTRE ;
A. A. ARTENIE ;
N. MINOYAN ;
D. JUTRAS-ASWAD ;
J. GREBELY ;
J. BRUNEAU
|
2021
Dans International Journal of Drug Policy (Vol.96, October 2021) Article : Périodique
Dans International Journal of Drug Policy (Vol.96, October 2021) Article : Périodique
Background: Frequent injecting increases hepatitis C (HCV) acquisition risk among people who inject drugs (PWID). However, few studies have examined how temporal fluctuations in injecting frequency may affect HCV infection risk. Thus, this study[...]